FOXO3 and breast carcinoma: Silencing endogenous FOXO3a expression protected breast cancer cells from apoptosis and cell cycle arrest, and abrogated the increased p53, p21, and growth arrest and DNA damage-inducible proteins (GADD45) signaling activity following quercetin treatment.